1
SINCE 1845 Source: The Straits Times © Singapore Press Holdings Limited. Permission required for reproduction. | WEDNESDAY, FEBRUARY 22, 2017 | THE STRAITS TIMES | BUSINESS C5 Q How did the company start? A It started 35 years ago as a tool-making company that went by another name. It then went on to de- sign plastic injection moulds. Back then, it served all kinds of in- dustries. But about 20 years ago, the com- pany shifted towards serving only the medical industry. The medical industry is more sta- ble and requires more precision – it’s an area we can compete in as a Singapore company. Our costs are high and labour is in short supply. The company was renamed In- zign – which stands for innovation and design – about 15 years ago. We’re now a contract manufactur- er serving the medical industry – un- like our peers, who might also work with industries like automotive and consumer electronics. Q How have you sought to grow the business in recent years? A We have been serving the medical therapeutic industry, supplying drug delivery devices such as inhal- ers, injection devices, disposables and transfusion devices. In the last few years, we’ve identi- fied medical diagnostics as a key growth area, and have started put- ting resources there and investing in equipment. These include plastic disposables used in drawing blood and in blood tests, for instance. We found that the big pharmaceu- tical companies have very estab- lished supplier bases, so it would be very tough for us to break into the market. Instead, we identified some start-ups – which are open to new suppliers – as possible targets. We were also approached by ET- PL, the commercialisation arm of the Agency for Science, Technolo- gy and Research (A*Star). They had been working in the area of micro- fluidics, which is the science of ma- nipulating and controlling very small amounts of fluids. ETPL said the industry has good prospects and asked if we were in- terested in exploring opportunities. We see microfluidics devices as next-generation diagnostics prod- ucts. For instance, existing blood tests need about 5ml of blood. But with microfluidics, the sample size comes down tremendously – just a drop, or about 0.5ml, is needed. This is a new area, so there are few established players; people are still coming up with new ideas. Q How did you start venturing into the microfluidics space? A ETPL linked us up with the Singapore Institute of Manufactur- ing Technology (SIMTech), which had ready microfluidics technology. We signed a technology licensing deal with ETPL to produce these de- vices. SIMTech helped with ready- ing the devices for large-scale manu- facturing, while we brought in the machinery and set up the produc- tion line. Besides supplying the technology, SIMTech also intro- duced some customers to us. We have invested more than $2 million in new production facilities for microfluidics, and are at differ- ent stages of the innovation and pro- duction process with various cus- tomers. Examples of microfluidics devices the company is working on include 3D cell culture tools, testing chips for the Zika virus as well as cell separation chips. We’re beginning to see some progress, with some devices going in- to production this year, so we should see returns from the investments we have made. We expect strong de- mand for the 3D cell culture tools and cell separation chips this year. Q How big is the company? A We operate three production facil- ities – two of them here and one in Batam to take advantage of the low- er overheads there. We have 110 staff members in Singapore and 30 to 40 in Batam. But the technical expertise – engi- neers and managers – is all here. In Batam, we just operate a skeleton production crew. We tend to be a little bit choosy about which customers we work for; not all products are suitable for us. We operate clean rooms and we have a certain cost structure. Some customers might prefer low- er-cost service providers. We made $19 million in revenue last year and expect to do $23 million this year. [email protected] SMESpotlight Mr Lau says Inzign has carved out a niche for itself by focusing on manufacturing exclusively for the medical device industry and supplying to start-ups. ST PHOTO: CHEW SENG KIM Innovating to serve medical sector better The medical device sector has traditionally been dominated by large incumbents, but local medical and healthcare device manufacturer Inzign is on track to making its mark. In the third of a four-part series about small firms with disruptive technologies, Mr Steven Lau, director of product development, tells Chia Yan Min about the company’s expansion plans.

ST CAUSES WEEK THESTRAITSTIMES Home C5 …PONY MA, founder, CEO and executive director of Tencent Holdings NADIEM MAKARIM, founder and CEO of Go-Jek BINNY BANSAL and SACHIN BANSAL,

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: ST CAUSES WEEK THESTRAITSTIMES Home C5 …PONY MA, founder, CEO and executive director of Tencent Holdings NADIEM MAKARIM, founder and CEO of Go-Jek BINNY BANSAL and SACHIN BANSAL,

SINCE 1845

78PAGES INFIVEPARTS$1.10Tosubscribe: 6388-3838sphsubscription.com.sg

ASingaporePressHoldingspublication

MCI (P)041/02/2016��

RaviVelloor

Seven people operating at the fron-tiers of technology’s interface withbusiness, collectively called “TheDisruptors”, are this year’s StraitsTimesAsiansof theYear.Mr Nadiem Makarim of Go-Jek,

Mr Anthony Tan and Ms Tan HooiLing of Grab, Mr Tan Min-Liang ofRazer, Mr Pony Ma of Tencent and

Mr Sachin Bansal and Mr BinnyBansal of Flipkartwere chosen fromacrowded fieldby theeditors ofTheStraitsTimesfor theannualaward.Breaking from tradition, editors

of the 171-year-old newspaper thisyear chose tonamea cluster of indi-viduals, recognising that credit forthe changes sweeping the conti-nent are too widespread to bepinned to a single individual’sbreast. Accordingly, the names in-

clude business leaders from Asia’sbig-population nations – China, In-dia and Indonesia – as well as fromMalaysia andSingapore.The award citation noted that

each, in his or her own way, had“made the inevitablemarchof tech-nology easier to understand andac-cept by millions of people con-cerned about their old ways of lifeyielding toanunfamiliarnewone”.Selection committee chairman

Warren Fernandez, who is the edi-tor-in-chief of the English, MalayandTamilMediaGroupofSingaporePress Holdings as well as ST editor,notedthat2016hadbeenanespecial-ly surprising year politically. “Thesesurprises are driven by underlyingforces of major technological andeconomic change brought about bythe disruption that is sweepingacross just about every sector of oureconomies and societies. Exactly

howpeople, governments andbusi-nesses respond to these changeswillhavemajorpolitical andelector-al implications in theyears ahead.”The Asian of the Year award rec-

ognises a person or people whohave contributed significantly toimproving lives at home or in thewider region. The inaugural Asianof theYear, in 2012,was thenMyan-mar President Thein Sein. The fol-lowing year, the award was shared

by Prime Minister Shinzo Abe ofJapan and President Xi Jinping ofChina. In 2014, the award went toIndia’s Prime Minister NarendraModi and, last year, it was awardedposthumously to Mr Lee KuanYew, Singapore’s founding father.

[email protected]

SEE TOP OF THE NEWS A4,EDITORIAL A19

CharissaYong

The growing mood of anxiety anddiscontent and the ground gainedby extreme political parties inmany developed countries will im-pact not just the world economy,but global security and stability,Prime Minister Lee Hsien Loongsaidyesterday.There will be major consequenc-

es for small, open countries such

as Singapore that have relied onopen trade and making friends,and sought opportunities to coop-erate, he said.Itwill alsobeharder to prosper to-

gether in this new climate, wherecountriesare turning inwardandbe-coming more protectionist, seeingothers’gainsas their loss,headded.Mr Lee gave this reading of recent

trends in a speech to 2,500 People’sAction Party (PAP) members attheirbiennialpartyconference.

He called on members to under-standwhat the trendmeans for Sin-gapore and to help ensure the PAPremains a party with strong sup-port fromall segmentsof society.“The externalworld is changing...

in a very fundamental way not ad-vantageous to us.We have towatchthis,wehave toknowhowthis isgo-ing to impact us over the next fewyears,”he said.MrLee,whoisPAPsecretary-gen-

eral, noted that voters around theworld are unhappy that the benefitsof growth are not reaching them,and feel threatened that immigrantsarecompetingfor their jobs.He cited the recent United States

election, the Brexit vote and therise of extreme parties in Europe asexamples of voters’ weariness oftradeandwarinessof immigrants.“This looks like the trend now. I

do not know how far it will go, but Idonot like the direction the trend isgoing,” he said. “If more countriesturn this way, the world is going tochange, andchange for theworse.”Singapore prospered in the past

50 years by working hard, but itwas fortunate to have a favourableexternal environment: A peacefulAsia and an international orderwherecountries bigandsmall coop-erate and compete under rules thatare fair to all, giving small countries

“a right to their place in the sun”.Today, countries are flexing

their muscles and becoming in-creasingly assertive.“Nobodycantell howrelationsbe-

tween the big powerswill develop,”said Mr Lee. “If US-China relationsgrow tense, Singapore is going tobein a very difficult spot, because weregardboth theUS andChina as ourfriends and do not want to have tochoosebetween them.”Meanwhile, obstacles to trade are

increasing and Singapore’s exports– a key pillar of its economy – arenotgrowingbyverymucheither.But Singapore has to accept the

world as it is, not as it wishes it tobe, saidMrLee.“Weourselvesmust remain open,

because if we close up like othercountries, our people will be fin-ished,”he said.Besides understanding the global

climate, Mr Lee spelt out two otherways for the ruling party to preparefor the next general election,whichmustbeheldbyApril 2021.First, the party must strive to im-

prove the lives of Singaporeans.He cited twoways of doing so: By

equipping Singaporeans with theskills to take care of themselvesthrough schools and training pro-grammes, and by strengthening so-cial safetynets.Second, the PAP must remain a

strong, national party that reachesout to all segments of society andrepresents them. It must also stayfocused on serving the people, andprovide strong leadership, he said.“Politics is the same everywhere.

It is people, it is trust, it is knowingyoucare forme,”headded.“Unless we have this deep in our

DNA,wewill not be able to hold ourposition inSingapore.”

[email protected]

SEE TOP OF THE NEWS A8

PM: Rising global discontentwill affect stability, securityItwill be harder toprosper together, andS’poremust keepwatchover impact of trend

THE DISRUPTORSS T R A I T S T I M E S A S I A N S O F T H E Y E A R

PONY MA, founder, CEOand executive director

of Tencent HoldingsNADIEM MAKARIM, founder and CEO of Go-Jek

BINNY BANSAL and SACHIN BANSAL, co-founders of Flipkart

ANTHONY TAN and TAN HOOI LING, co-founders of Grab

TAN MIN-LIANG, co-founder and CEO of Razer Inc

EXCELLENCE IN REDESIGN: SOCIETY OF NEWS DESIGN BEST IN NEWSPAPER DESIGN, BEST NEWS WEBSITE: WAN-IFRA

World Tempest over Trump’s Taiwan phone call A10 • Education Is PSLE a necessary checkpoint? B10&11

HomeDelivered food? Prepare to pay more B1

Serving up friendship with meals

Connecting home cooks to customers

ST CAUSES WEEK Top of the News A6 SportRunner dies during marathon raceC12

dies during marathon

Source: The Straits Times © Singapore Press Holdings Limited. Permission required for reproduction.

QHowdid thecompanystart?A It started 35 years ago as atool-making company that went byanothername. It thenwenton tode-signplastic injectionmoulds.Back then, it servedall kindsof in-

dustries.But about 20 years ago, the com-

pany shifted towards serving onlythemedical industry.Themedical industry is more sta-

ble and requires more precision –it’s an area we can compete in as aSingapore company. Our costs arehighand labour is in short supply.The company was renamed In-

zign – which stands for innovationanddesign–about 15years ago.We’renowacontractmanufactur-

er serving themedical industry–un-like our peers, whomight also workwith industries like automotive andconsumerelectronics.

QHowhaveyousought togrow thebusiness in recent years?AWehavebeenserving themedicaltherapeutic industry, supplyingdrug delivery devices such as inhal-ers, injection devices, disposablesandtransfusiondevices.In the last fewyears,we’ve identi-

fied medical diagnostics as a keygrowth area, and have started put-ting resources there and investingin equipment. These include plasticdisposables used in drawing bloodand inblood tests, for instance.Wefoundthat thebigpharmaceu-

tical companies have very estab-lished supplier bases, so it would bevery tough for us to break into themarket. Instead,we identified somestart-ups – which are open to newsuppliers–aspossible targets.We were also approached by ET-

PL, the commercialisation arm ofthe Agency for Science, Technolo-gy andResearch (A*Star). They hadbeen working in the area of micro-fluidics, which is the science ofma-nipulating and controlling verysmall amounts of fluids.ETPL said the industry has good

prospects and asked if we were in-terested inexploringopportunities.We see microfluidics devices as

next-generation diagnostics prod-ucts. For instance, existing bloodtests need about 5ml of blood. Butwith microfluidics, the sample sizecomes down tremendously – just adrop,orabout0.5ml, isneeded.This is anewarea, so thereare few

established players; people are stillcomingupwithnewideas.

QHowdidyoustart venturing intothemicrofluidics space?AETPLlinkedusupwith theSingapore Institute of Manufactur-

ing Technology (SIMTech), whichhad readymicrofluidics technology.We signed a technology licensing

dealwithETPLtoproduce thesede-vices. SIMTech helped with ready-ingthedevices for large-scalemanu-facturing, while we brought in themachinery and set up the produc-tion line. Besides supplying thetechnology, SIMTech also intro-ducedsomecustomers tous.We have invested more than $2

million in new production facilitiesfor microfluidics, and are at differ-ent stagesof the innovationandpro-duction process with various cus-tomers. Examples of microfluidics

devices the company is working oninclude3Dcell culture tools, testingchips for the Zika virus as well ascell separationchips.We’re beginning to see some

progress,withsomedevicesgoingin-toproductionthisyear, soweshouldseereturns fromtheinvestmentswehave made. We expect strong de-mand for the 3D cell culture toolsandcell separationchipsthisyear.

QHowbig is thecompany?AWeoperate threeproductionfacil-ities – two of them here and one inBatam to take advantage of the low-er overheads there. We have 110

staff members in Singapore and 30to40inBatam.But the technical expertise–engi-

neers andmanagers – is all here. InBatam, we just operate a skeletonproductioncrew.We tend to be a little bit choosy

about which customers we workfor; not all products are suitable forus. We operate clean rooms and wehaveacertaincost structure.Somecustomersmightprefer low-

er-cost service providers. We made$19 million in revenue last year andexpect todo$23million thisyear.

[email protected]

SMESpotlight

Mr Lau saysInzign hascarved out aniche for itselfby focusing onmanufacturingexclusively forthe medicaldevice industryand supplying tostart-ups.ST PHOTO:CHEW SENG KIM

Innovating toservemedicalsector better

Noone remains in their comfortzoneat 3M,adiversifiedconglomeratebestknownas themakerofPost-it notes, andacompany thathasbuilt areputationof innovationover time.3Mensures “every talentmove is

adeliberatemove”, employeeshaveseveral skills andencouragesconstant collaboration, amongother things,noted3MmanagingdirectorYukoNakahira.Shesaid: “When thenotionof

staying inone’s comfort zonekicksin, this in itself is self-limiting fortheemployeesandalso for theorganisation. It impedes3Mfromstayingcompetitive andagile toadaptand transform.”Investing inhumancapital

turned3Minto a “morenimbleorganisation to serve customersbetter”. Takeanexampleon theproduction floor,whereemployeesare equippedwithdifferent skills needed to runmultipleoperations.What thismeans is thatwhen

productiondemands fluctuate,employeescanbeeasilymoved toother areas, and that is alsopartoftheirdevelopment.“In the longer term, theycould

grow into subjectmatter experts incertainprocessesandcontributein the technical area,” sheadded.Thishas led to lower

attritionrates andbetter

employee retention.Thedrive formultiple skills has

alsoencouraged its foreignandlocal employees to learn fromeachother.MsNakahira said: “Foreigntalentwithextensive internationalexperienceandglobal networksare sometimesbrought in totransfer skills andcompetenciesnot available locally.”Shenoted the transfer and

exchangeof local and foreignskillsand talent is notone-way.Andbuildingglobal anddiverse talentisoneof the firm’s strategies.“Humancapital development is

an integral part ofourbusinessstrategy, asweneed the righttalentwith the right competenciestomeet3M’s goals andobjectives,”saidMsNakahira.Researchanddevelopment

manufacturingengineers areexposed todifferentprocessesor

product lines, andget tomoveupthe technical ormanagementladder, for instance.The firmalsosponsors studies, sends staff toexternal courses, andhas its ownprogrammes, suchaswhat is calledtheLeaders-Teach-LeadersConcept, runby themanagement.With suchpractices, employees

becomemorecommittedand fullyengaged, taking “pride inbeinga3M-er”. 3Mhasbeen inSingaporesince 1966, startingwitheightemployees, andnowhasmore than1,600.Therearealsoplans for 3M’sworkforce–some90,000employees in 70countries—tobeactively involved indevelopmentopportunitiesby2025. The firm ispartof theHumanCapitalPartnershipProgramme.Of theprogramme,MsNakahira

said: “Wetakepride inbeingpartof thecommunity tohelp shape

thehumancapital plan forSingapore.Wealsowish to learnfromthebestpractices fromotherpeercompanies. “Thisenhancesouremploymentbrandandwouldhaveapositive impactonourrecruitment, engagementandretentionefforts. Ithelps ensurethatwehave the right talent tokeep3Mat the forefrontofimproving lives around theworldthroughscience.”Local talent also get to showcase

and transfer their skills overseas,and this is in linewithdevelopingastrongerSingaporeancore, a keyaimof theHumanCapitalPartnershipProgramme.“WehavemanySingaporeans in

Singapore-based roles coveringtheAsia-Pacific region– theytravelwidely in the region, sharingtheir skills andexpertisewithourcolleagues inother countries.

“WealsohaveSingaporeanstakingupoverseas assignments,broadening theirhorizons andgainingmoreexposure.Agreatexample isMrArthurFong, formermanagingdirectorof3MSingapore,who recently relocatedtoChina to lead the large3MIndustrialBusiness there,” saidMsNakahira.Asa science-basedcompanyand

“anequal-opportunity employer”,shenoted that collaboration iscrucial to the success of3M’sinnovationengine.“At3M,wework in anengaging

andcollaborativeenvironmentwhere ideasare shared freely;where there is diversity, thefreedomtoexplore andopencommunication.This is evidentthrough thewaywehelpouremployees todevelop and transferskills.”

In the secondof a five-part serieswhereleadersunder theHumanCapital PartnershipProgrammeshare their thoughts ondeveloping talent for a strongcore,3Mmanagingdirector YukoNakahira speakstoXinYunabout the transfer of capabilitiesbetween foreignand local employees.

Ms Yuko Nakahira, managing director of 3M; Mr Eugene Chew, senior manager of 3M’s Tuas plant; and Mr Mark Ratzlaff,South-east Asia regional manufacturing operations manager, 3M Southeast Asia Region. ST PHOTO: DESMOND WEE

When the 3M Tuas plant wasset up in 2010, Mr Mark Ratz-laff was transferred to Singa-pore from the United States tohelp start the new operationsand train the local teams.Hementored3MSingapore’s

Mr Eugene Chew, who wasthen a production manager,and used his technical know-ledge to train the local engi-neeringandproductionteams.Having learnt fromMr Ratz-

laff about the operations, MrChewwas able to take over hisposition when Mr Ratzlaff re-turned to the US, andMrChewbecame the new productman-ager for the display materialsandsystemsdivision in2012.3M managing director Yuko

Nakahira said: “True to the 3Mstrategy of developing glo-balised leaders, Mark has re-cently returned to Singaporeto assume the role of South-east Asia regionalmanufactur-ingoperationsmanager.”Mr Chew, who started his

career in 3M as a flex processengineer in 2004, later paid itforward by developing Mr Pe-ter Huang, who eventually be-came the process engineeringmanager for thedisplaymateri-als andsystemsdivision.

Themedical device sector hastraditionally beendominatedbylarge incumbents, but localmedical andhealthcaredevicemanufacturer Inzign is on tracktomaking itsmark. In the thirdofa four-part series about smallfirmswithdisruptivetechnologies,MrStevenLau,director of product development,tellsChiaYanMinabout thecompany’s expansionplans.

The Human Capital Conversation

Developing local talent through skills transfer

SPONSOREDCONTENT

Brought toyouby

In the spotlight

THEPROGRAMME

The Human Capital Partnership(HCP) Programme is a tripartiteinitiative to growa community ofexemplary employers focusedonstaying competitive by investing inhumancapital development.HCP recognises and supportsemployers committed toprogrammes that nurture astronger SingaporeanCore;maximises complementaritybetween locals and foreigners; andenhances skills transfer fromforeign to local employees in orderto increase the capabilities of thelocalworkforce.

To find outmore on how you can bepart of theHCPProgramme,contact Tafep (Tripartite Alliancefor Fair and ProgressiveEmploymentPractices), theHCPprogrammemanager at6302-2782, e-mail us [email protected] or visithttps://www.tafep.sg/human-capital-partnership-programmeformore information.

| WEDNESDAY, FEBRUARY 22, 2017 | THE STRAITS TIMES | BUSINESS C5

QHowdid thecompanystart?A It started 35 years ago as atool-making company that went byanothername. It thenwenton tode-signplastic injectionmoulds.Back then, it servedall kindsof in-

dustries.But about 20 years ago, the com-

pany shifted towards serving onlythemedical industry.Themedical industry is more sta-

ble and requires more precision –it’s an area we can compete in as aSingapore company. Our costs arehighand labour is in short supply.The company was renamed In-

zign – which stands for innovationanddesign–about 15years ago.We’renowacontractmanufactur-

er serving themedical industry–un-like our peers, whomight also workwith industries like automotive andconsumerelectronics.

QHowhaveyousought togrow thebusiness in recent years?AWehavebeenserving themedicaltherapeutic industry, supplyingdrug delivery devices such as inhal-ers, injection devices, disposablesandtransfusiondevices.In the last fewyears,we’ve identi-

fied medical diagnostics as a keygrowth area, and have started put-ting resources there and investingin equipment. These include plasticdisposables used in drawing bloodand inblood tests, for instance.Wefoundthat thebigpharmaceu-

tical companies have very estab-lished supplier bases, so it would bevery tough for us to break into themarket. Instead,we identified somestart-ups – which are open to newsuppliers–aspossible targets.We were also approached by ET-

PL, the commercialisation arm ofthe Agency for Science, Technolo-gy andResearch (A*Star). They hadbeen working in the area of micro-fluidics, which is the science ofma-nipulating and controlling verysmall amounts of fluids.ETPL said the industry has good

prospects and asked if we were in-terested inexploringopportunities.We see microfluidics devices as

next-generation diagnostics prod-ucts. For instance, existing bloodtests need about 5ml of blood. Butwith microfluidics, the sample sizecomes down tremendously – just adrop,orabout0.5ml, isneeded.This is anewarea, so thereare few

established players; people are stillcomingupwithnewideas.

QHowdidyoustart venturing intothemicrofluidics space?AETPLlinkedusupwith theSingapore Institute of Manufactur-

ing Technology (SIMTech), whichhad readymicrofluidics technology.We signed a technology licensing

dealwithETPLtoproduce thesede-vices. SIMTech helped with ready-ingthedevices for large-scalemanu-facturing, while we brought in themachinery and set up the produc-tion line. Besides supplying thetechnology, SIMTech also intro-ducedsomecustomers tous.We have invested more than $2

million in new production facilitiesfor microfluidics, and are at differ-ent stagesof the innovationandpro-duction process with various cus-tomers. Examples of microfluidics

devices the company is working oninclude3Dcell culture tools, testingchips for the Zika virus as well ascell separationchips.We’re beginning to see some

progress,withsomedevicesgoingin-toproductionthisyear, soweshouldseereturns fromtheinvestmentswehave made. We expect strong de-mand for the 3D cell culture toolsandcell separationchipsthisyear.

QHowbig is thecompany?AWeoperate threeproductionfacil-ities – two of them here and one inBatam to take advantage of the low-er overheads there. We have 110

staff members in Singapore and 30to40inBatam.But the technical expertise–engi-

neers andmanagers – is all here. InBatam, we just operate a skeletonproductioncrew.We tend to be a little bit choosy

about which customers we workfor; not all products are suitable forus. We operate clean rooms and wehaveacertaincost structure.Somecustomersmightprefer low-

er-cost service providers. We made$19 million in revenue last year andexpect todo$23million thisyear.

[email protected]

SMESpotlight

Mr Lau saysInzign hascarved out aniche for itselfby focusing onmanufacturingexclusively forthe medicaldevice industryand supplying tostart-ups.ST PHOTO:CHEW SENG KIM

Innovating toservemedicalsector better

Noone remains in their comfortzoneat 3M,adiversifiedconglomeratebestknownas themakerofPost-it notes, andacompany thathasbuilt areputationof innovationover time.3Mensures “every talentmove is

adeliberatemove”, employeeshaveseveral skills andencouragesconstant collaboration, amongother things,noted3MmanagingdirectorYukoNakahira.Shesaid: “When thenotionof

staying inone’s comfort zonekicksin, this in itself is self-limiting fortheemployeesandalso for theorganisation. It impedes3Mfromstayingcompetitive andagile toadaptand transform.”Investing inhumancapital

turned3Minto a “morenimbleorganisation to serve customersbetter”. Takeanexampleon theproduction floor,whereemployeesare equippedwithdifferent skills needed to runmultipleoperations.What thismeans is thatwhen

productiondemands fluctuate,employeescanbeeasilymoved toother areas, and that is alsopartoftheirdevelopment.“In the longer term, theycould

grow into subjectmatter experts incertainprocessesandcontributein the technical area,” sheadded.Thishas led to lower

attritionrates andbetter

employee retention.Thedrive formultiple skills has

alsoencouraged its foreignandlocal employees to learn fromeachother.MsNakahira said: “Foreigntalentwithextensive internationalexperienceandglobal networksare sometimesbrought in totransfer skills andcompetenciesnot available locally.”Shenoted the transfer and

exchangeof local and foreignskillsand talent is notone-way.Andbuildingglobal anddiverse talentisoneof the firm’s strategies.“Humancapital development is

an integral part ofourbusinessstrategy, asweneed the righttalentwith the right competenciestomeet3M’s goals andobjectives,”saidMsNakahira.Researchanddevelopment

manufacturingengineers areexposed todifferentprocessesor

product lines, andget tomoveupthe technical ormanagementladder, for instance.The firmalsosponsors studies, sends staff toexternal courses, andhas its ownprogrammes, suchaswhat is calledtheLeaders-Teach-LeadersConcept, runby themanagement.With suchpractices, employees

becomemorecommittedand fullyengaged, taking “pride inbeinga3M-er”. 3Mhasbeen inSingaporesince 1966, startingwitheightemployees, andnowhasmore than1,600.Therearealsoplans for 3M’sworkforce–some90,000employees in 70countries—tobeactively involved indevelopmentopportunitiesby2025. The firm ispartof theHumanCapitalPartnershipProgramme.Of theprogramme,MsNakahira

said: “Wetakepride inbeingpartof thecommunity tohelp shape

thehumancapital plan forSingapore.Wealsowish to learnfromthebestpractices fromotherpeercompanies. “Thisenhancesouremploymentbrandandwouldhaveapositive impactonourrecruitment, engagementandretentionefforts. Ithelps ensurethatwehave the right talent tokeep3Mat the forefrontofimproving lives around theworldthroughscience.”Local talent also get to showcase

and transfer their skills overseas,and this is in linewithdevelopingastrongerSingaporeancore, a keyaimof theHumanCapitalPartnershipProgramme.“WehavemanySingaporeans in

Singapore-based roles coveringtheAsia-Pacific region– theytravelwidely in the region, sharingtheir skills andexpertisewithourcolleagues inother countries.

“WealsohaveSingaporeanstakingupoverseas assignments,broadening theirhorizons andgainingmoreexposure.Agreatexample isMrArthurFong, formermanagingdirectorof3MSingapore,who recently relocatedtoChina to lead the large3MIndustrialBusiness there,” saidMsNakahira.Asa science-basedcompanyand

“anequal-opportunity employer”,shenoted that collaboration iscrucial to the success of3M’sinnovationengine.“At3M,wework in anengaging

andcollaborativeenvironmentwhere ideasare shared freely;where there is diversity, thefreedomtoexplore andopencommunication.This is evidentthrough thewaywehelpouremployees todevelop and transferskills.”

In the secondof a five-part serieswhereleadersunder theHumanCapital PartnershipProgrammeshare their thoughts ondeveloping talent for a strongcore,3Mmanagingdirector YukoNakahira speakstoXinYunabout the transfer of capabilitiesbetween foreignand local employees.

Ms Yuko Nakahira, managing director of 3M; Mr Eugene Chew, senior manager of 3M’s Tuas plant; and Mr Mark Ratzlaff,South-east Asia regional manufacturing operations manager, 3M Southeast Asia Region. ST PHOTO: DESMOND WEE

When the 3M Tuas plant wasset up in 2010, Mr Mark Ratz-laff was transferred to Singa-pore from the United States tohelp start the new operationsand train the local teams.Hementored3MSingapore’s

Mr Eugene Chew, who wasthen a production manager,and used his technical know-ledge to train the local engi-neeringandproductionteams.Having learnt fromMr Ratz-

laff about the operations, MrChewwas able to take over hisposition when Mr Ratzlaff re-turned to the US, andMrChewbecame the new productman-ager for the display materialsandsystemsdivision in2012.3M managing director Yuko

Nakahira said: “True to the 3Mstrategy of developing glo-balised leaders, Mark has re-cently returned to Singaporeto assume the role of South-east Asia regionalmanufactur-ingoperationsmanager.”Mr Chew, who started his

career in 3M as a flex processengineer in 2004, later paid itforward by developing Mr Pe-ter Huang, who eventually be-came the process engineeringmanager for thedisplaymateri-als andsystemsdivision.

Themedical device sector hastraditionally beendominatedbylarge incumbents, but localmedical andhealthcaredevicemanufacturer Inzign is on tracktomaking itsmark. In the thirdofa four-part series about smallfirmswithdisruptivetechnologies,MrStevenLau,director of product development,tellsChiaYanMinabout thecompany’s expansionplans.

The Human Capital Conversation

Developing local talent through skills transfer

SPONSOREDCONTENT

Brought toyouby

In the spotlight

THEPROGRAMME

The Human Capital Partnership(HCP) Programme is a tripartiteinitiative to growa community ofexemplary employers focusedonstaying competitive by investing inhumancapital development.HCP recognises and supportsemployers committed toprogrammes that nurture astronger SingaporeanCore;maximises complementaritybetween locals and foreigners; andenhances skills transfer fromforeign to local employees in orderto increase the capabilities of thelocalworkforce.

To find outmore on how you can bepart of theHCPProgramme,contact Tafep (Tripartite Alliancefor Fair and ProgressiveEmploymentPractices), theHCPprogrammemanager at6302-2782, e-mail us [email protected] or visithttps://www.tafep.sg/human-capital-partnership-programmeformore information.

| WEDNESDAY, FEBRUARY 22, 2017 | THE STRAITS TIMES | BUSINESS C5